Next Financial Group’s 10x Genomics TXG Stock Holding History

Next Financial Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$59K	Buy	394 +273	+226%	+$41.8K	﹤0.01%	1404
2021 Q3	$18K	Hold	121	–	–	﹤0.01%	1841
2021 Q2	$24K	Buy	121 +38	+46%	+$6.88K	﹤0.01%	1684
2021 Q1	$15K	Buy	83 +76	+1,086%	+$13.1K	﹤0.01%	1752
2020 Q4	$1K	Sell	7 -415	-98%	-$60.2K	﹤0.01%	2309
2020 Q3	$53K	Buy	+422	New	+$44.3K	0.01%	1088

Other funds holding TXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Next Financial Group's TXG Position: Q4 2021 in Review

Next Financial Group increased its 10x Genomics (TXG) stake by 226% in Q4 2021, buying an estimated $41.8K and bringing the position to 394 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Next Financial Group first reported a position in TXG in Q3 2020 and has held it in 6 quarters since. 365 funds tracked by Wall St. Rank hold TXG as of Q4 2021.

Next Financial Group held 394 shares of 10x Genomics worth $59K as of Q4 2021.
Next Financial Group bought 273 10x Genomics shares in Q4 2021, an estimated $41.8K.
10x Genomics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #1404 holding.
Next Financial Group first reported a position in 10x Genomics in Q3 2020 and has held it in 6 quarters since.
365 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.